The role of endogenous GLP-1 on insulin secretion during oral glucose tolerance test in healthy subjects and patients with type 2 diabetes mellitus

被引：0
|
作者：
Aulinger, B. A. [1 ]
Vahl, T. P. [1 ]
D'Alessio, D. A. [1 ]
Salehi, M. [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH USA
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0579
引用
收藏
页码：S240 / S240
页数：1
相关论文
共 50 条
  • [31] Insulin secretion in healthy subjects and patients with Type 2 diabetes - role of the gastrointestinal tract
    Ma, Jing
    Rayner, Christopher K.
    Jones, Karen L.
    Horowitz, Michael
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 413 - 424
  • [32] GLP-1 improves first phase insulin secretion without altering insulin sensitivity in subjects with impaired glucose tolerance
    Byrne, M
    Ulrich, W
    Katschinski, M
    Göke, B
    DIABETES, 1998, 47 : A192 - A192
  • [33] GLP-1 Action and Glucose Tolerance in Subjects With Remission of Type 2 Diabetes After Gastric Bypass Surgery
    Jimenez, Amanda
    Casamitjana, Roser
    Viaplana-Masclans, Judith
    Lacy, Antonio
    Vidal, Josep
    DIABETES CARE, 2013, 36 (07) : 2062 - 2069
  • [34] Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes
    S Temizkan
    O Deyneli
    M Yasar
    M Arpa
    M Gunes
    D Yazici
    O Sirikci
    G Haklar
    N Imeryuz
    D G Yavuz
    European Journal of Clinical Nutrition, 2015, 69 : 162 - 166
  • [35] Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes
    Temizkan, S.
    Deyneli, O.
    Yasar, M.
    Arpa, M.
    Gunes, M.
    Yazici, D.
    Sirikci, O.
    Haklar, G.
    Imeryuz, N.
    Yavuz, D. G.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2015, 69 (02) : 162 - 166
  • [36] GLP-1 as a Therapeutic Agent in Patients with Type 2 Diabetes Mellitus
    Legakis, Ioannis
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2007, 1 (03) : 193 - 201
  • [37] Unchanged, but correlated secretion of the incretin hormones GIP and GLP-1 after oral glucose in first degree relatives of Type 2 diabetic patients and healthy subjects
    El-Ouaghlidi, A
    Meier, JJ
    Gabrys, B
    Huecking, K
    Holst, JJ
    Deacon, CF
    Gallwitz, B
    Schmidt, WE
    Nauck, MA
    DIABETOLOGIA, 2002, 45 : A216 - A216
  • [38] The Effect of Ursodeoxycholic Acid Added to Dipeptidyl Peptidase-4 Inhibitor on GLP-1 Secretion and Glucose Tolerance in Subjects with Type 2 Diabetes
    Shima, Kosuke R.
    Takeshita, Yumie
    Ota, Tsuguhito
    Misu, Hirofumi
    Takamura, Toshinari
    DIABETES, 2017, 66 : A312 - A312
  • [39] Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects
    P A Velasquez-Mieyer
    P A Cowan
    G E Umpierrez
    R H Lustig
    A K Cashion
    G A Burghen
    International Journal of Obesity, 2003, 27 : 1359 - 1364
  • [40] Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects
    Velasquez-Mieyer, PA
    Cowan, PA
    Umpierrez, GE
    Lustig, RH
    Cashion, AK
    Burghen, GA
    INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (11) : 1359 - 1364
12345